Service use: Emergency medical/dental treatment · People with serious mental illness (all included participants had schizophrenia); majority aged 18 to 65 years per NIMH 1987, or with…
The review found no eligible studies for this question.
1 finding from 1 review
Denture plaque · Residents of institutions for elderly people (nursing staff and residents took part in the education programme)
1 finding from 1 review
One study (Schou 1989), at unclear risk of bias and analysing 114 residents, provided insufficient evidence to determine whether denture plaque scores are lower when educating residents or nursing staff without…
1 study · 114 participants
GRADE not reported
Adverse events: Clinically important specific adverse events · People with serious mental illness (all included participants had schizophrenia); majority aged 18 to 65 years per NIMH 1987, or with…
The review found no eligible studies for this question.
1 finding from 1 review
Dental state: No clinically important change in plaque index · People with serious mental illness (all included participants had schizophrenia); majority aged 18 to 65 years per NIMH 1987, or with…
The review found no eligible studies for this question.
1 finding from 1 review
Leaving the study early · People with serious mental illness (all included participants had schizophrenia); majority aged 18 to 65 years per NIMH 1987, or with…
Monitoring (any means of observation, supervision, keeping under… showed no clear difference in leaving the study early compared with no monitoring (moderate certainty).
1 finding from 1 review
Medically fit for discharge · patients with perioperative fluid optimization
1 finding from 1 review
Return to pre‐fracture accommodation/return to pre‐fracture mobility · patients with perioperative fluid optimization
1 finding from 1 review
Adverse outcomes ‐ cardiopulmonary · patients with perioperative fluid optimization
1 finding from 1 review
Adverse outcomes ‐ neurological · patients with perioperative fluid optimization
Advanced haemodynamic monitoring showed no clear difference in adverse outcomes ‐ neurological compared with usual care (low certainty).
1 finding from 1 review
Adverse outcomes ‐ all · patients with perioperative fluid optimization
Advanced haemodynamic monitoring showed no clear difference in adverse outcomes ‐ all compared with usual care (low certainty).
1 finding from 1 review
All‐cause mortality · patients with perioperative fluid optimization
Protocol using standard measures such as CVP showed no clear difference in all‐cause mortality compared with usual care (low certainty).
1 finding from 1 review
Length of hospital stay · patients with perioperative fluid optimization
1 finding from 1 review
Medically fit for discharge · patients with perioperative fluid optimization
1 finding from 1 review
Return to pre‐fracture accommodation/return to pre‐fracture mobility · patients with perioperative fluid optimization
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse outcomes ‐ cardiopulmonary · patients with perioperative fluid optimization
1 finding from 1 review
Adverse outcomes ‐ neurological · patients with perioperative fluid optimization
Protocol using standard measures such as CVP showed no clear difference in adverse outcomes ‐ neurological compared with usual care (low certainty).
1 finding from 1 review
Adverse outcomes ‐ all · patients with perioperative fluid optimization
Protocol using standard measures such as CVP showed no clear difference in adverse outcomes ‐ all compared with usual care (low certainty).
1 finding from 1 review
All‐cause mortality · patients with perioperative fluid optimization
Advanced haemodynamic monitoring showed no clear difference in all‐cause mortality compared with usual care (low certainty).
1 finding from 1 review
Length of hospital stay · patients with perioperative fluid optimization
1 finding from 1 review
Relapse, drop‐outs classed as relapse, grouped by length of · patients with maintenance of medically‐induced remission in Crohn's disease
5‐ASA showed no clear difference in relapse, drop‐outs classed as relapse, grouped by length of compared with placebo (moderate certainty).
3 findings from 1 review
RR 0.98 [0.91, 1.07]
11 studies · 2014 participants
Moderate
RR 0.99 [0.8, 1.23]
1 study · 161 participants
Low
RR 1.07 [0.86, 1.33]
1 study · 132 participants
Moderate